ERNA — Ernexa Therapeutics Inc.

ERNAErnexa Therapeutics Inc.

NAS · US · Healthcare · Biotechnology · ernexatx.com

11.28USD-5.92%Mkt Cap: 13.22M USDP/E: 0.01Last update: 2026-05-26

Ernexa Therapeutics Inc., a preclinical-stage company, develops induces derived mesenchymal stem cells (iMSC) therapies for the treatment of treatment of cancer and autoimmune disease. The company's lead product is ERNA-…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

39.41BUSDP/E 74.0

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap13.22M USD

Enterprise Value5.75M USD

Revenue (TTM)—

Gross Profit0 USD

Net Income (TTM)-14.08M USD

Revenue/Share—

Last Price11.28 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees5

CountryUS

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)0.01

P/E (Forward)-1.30

PEG—

EV/EBITDA-0.57

EV/Revenue—

P/S—

P/B40.72

EPS (TTM)1214.25

EPS (Forward)-9.60

52W Range

3.1809% of range90.00

52W High90.00 USD

52W Low3.180 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE-586.59%

ROA-241.41%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-7.02M USD

CapEx (TTM)37.00K USD

FCF Margin—

FCF Yield-74.29%

Net Debt-8.79M USD

Net Debt/EBITDA0.87

Balance Sheet

Debt/Equity0.20

Current Ratio2.89

Quick Ratio2.68

Book Value/Sh0.3060 USD

Cash/Share7.868 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:25

Split DateMay 4, 2026

Analyst Consensus

Rating1.0 (Strong Buy)

Target (Mean)30.00 USD

Target Range30.00 USD – 30.00 USD

# Analysts1

Ownership

Shares Out.1.17M

Float818.09K

Insiders41.78%

Institutions10.16%

Short Interest

Short Ratio0.2d

Short % Float0.73%

Short % Out.0.46%

Shares Short5.34K

Short (prev mo.)6.42K

Technical

SMA 506.525 (+72.9%)

SMA 20023.69 (-52.4%)

Beta—

S&P 52W Chg28.31%

Avg Vol (30d)3.36M

Avg Vol (10d)2.56M

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—